In animal models of myocardial ischemia, GLP-1 administration reduced infarct size, and in human subjects with acute myocardial infarction and severe systolic dysfunction after successful primary angioplasty, GLP-1 administration improved regional and global left ventricular function [128]. This evidence concerns the gene GLP1R and myocardial infarction.